// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Status of minimally invasive HPB surgery in the UK from consultant and trainee perspectives

A. Kourdouli - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The SWALIS 2020 new model to prioritize access to urgent, elective and backlog waiting lists. facing the challenge in the COVID era

S. Di Domenico - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Results from the European survey on preoperative management and optimization protocols for perihilar cholangiocarcinoma (PHC)

F. Ratti - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Advanced biliary tract carcinoma

N/A

Systematic review and meta-analysis of perioperative and long term outcomes after arterial resection for hilar cholangiocarcinoma

G. Mohammadi-Zaniani - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Klatskin tumors

N/A

Temporal changes in the prevalence of gallbladder dysplasia and adenocarcinoma in patients undergoing cholecystectomy and associated risk factors: a UK case-control study

S. Lam - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Tenability of selective histological examination of gallbladders following cholecystectomy operation: preliminary results of the S- GALLOP study

K. Dutt - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Gallbladder disease

N/A

Does the implementation of a clinical care pathway have an impact on early intravenous fluid therapy of acute pancreatitis? a pilot quality improvement study

D. Di Mauro - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Pancreatitis

N/A

Does vein groove positvity really affect overall survival in patients undergoing pancreatoduodenectomy for early stages of pancreatic ductal adenocarcinoma

M. Ahuja - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreas ductal adenocarcinoma

N/A

Early postoperative differentiation between biochemical leak and clinically-relevant postoperative pancreatic fistula after pancreaticoduodenectomy

S.S. Raza - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Endoscopic transmural drainage is associated with improved outcomes in disconnected pancreatic duct syndrome: a systematic review and meta-analysis

E. Chong - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Influence of middle hepatic vein resection during right or left hepatectomy on post hepatectomy outcomes

A. Nutu - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Liver resection in elderly with extended CRLM, is surgery still justified? A propensity score matched analysis

M. Di Martino - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

Improving outcomes amongst patients with clinically relevant pancreatic fistula after pancreatoduodenectomy

J. Halle-Smith - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

In-depth bioinformatic study of the Bcl-xL/Bcl2L1 gene in patients with pancreatic cancer

D. Magouliotis - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreato-biliary malignancies

N/A

Laparoscopic versus open management of chronic pancreatitis - a systematic review

A. Kourdouli - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Hereditary pancreatitis

N/A

New onset diabetes after partial pancreatectomy: development of a novel predictive model using machine learning

A. Borakati - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetes

N/A

Surgical management of hepatic echinococcus granulosus disease at a UK tertiary care centre

M. Karim - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The role of contrast-enhanced intraoperative ultrasound (CE-IOUS) in surgery for colorectal liver metastases: a meta-analysis

M. Fergadi - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

Validation of CT anatomical volumetry performed using hermes workstation

A. Nutu - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Role of neoadjuvant treatment in borderline and locally advanced pancreatic ductal adenocarcinoma: the leeds experience

N. Suresh - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreas ductal adenocarcinoma

N/A

Copyright © 2026. QuantiNova All rights reserved